🇺🇸 FDA
Patent

US 10988748

Compositions and methods for treating celiac sprue disease

granted A61KA61K38/00A61P

Quick answer

US patent 10988748 (Compositions and methods for treating celiac sprue disease) held by The Regents of the University of California expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00, A61P, A61P1/14